Follow
Radu Mitrut
Title
Cited by
Cited by
Year
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
A Tsatsakis, D Calina, L Falzone, D Petrakis, R Mitrut, V Siokas, M Pennisi, ...
Food and Chemical Toxicology 146, 111769, 2020
1752020
A mechanistic and pathophysiological approach for stroke associated with drugs of abuse
A Tsatsakis, AO Docea, D Calina, K Tsarouhas, LM Zamfira, R Mitrut, ...
Journal of Clinical Medicine 8 (9), 1295, 2019
1042019
Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections
O Zlatian, AT Balasoiu, M Balasoiu, O Cristea, AO Docea, R Mitrut, ...
Experimental and Therapeutic Medicine 16 (6), 4499-4510, 2018
582018
The incidence of skin lesions in contrast media-induced chemical hypersensitivity
AM Iordache, AO Docea, AM Buga, R Mitrut, D Albulescu, O Zlatian, ...
Experimental and therapeutic medicine 17 (2), 1113-1124, 2019
382019
Sildenafil and tadalafil reduce the risk of contrast-induced nephropathy by modulating the oxidant/antioxidant balance in a murine model
AM Iordache, AO Docea, AM Buga, O Zlatian, ME Ciurea, OC Rogoveanu, ...
Food and chemical toxicology 135, 111038, 2020
352020
Reversal of brain aging by targeting telomerase: A nutraceutical approach
D Tsoukalas, AM Buga, AO Docea, E Sarandi, R Mitrut, E Renieri, ...
International Journal of Molecular Medicine 48 (5), 1-11, 2021
322021
Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy
AM Iordache, AM Buga, D Albulescu, RC Vasile, R Mitrut, G Georgiadis, ...
Food and Chemical Toxicology 143, 111535, 2020
212020
Colorectal cancer and inflammatory bowel disease
P Mitrut, AO Docea, AM Kamal, R Mitrut, D Calina, E Gofita, V Padureanu, ...
Colorectal Cancer-from Pathogenesis to Treatment, L. Rodrigo, Ed, 185-199, 2016
192016
Histopathological aspects of the myocardium in dilated cardiomyopathy
R MITRUT, AE STEPAN, D PIRICI
Current health sciences journal 44 (3), 243, 2018
182018
Double therapy with pegylated interferon and ribavirin for chronic hepatitis C. A pharmacogenetic guide for predicting adverse events
AM Kamal, P Mitrut, AO Docea, SS Sosoi, CK Kamal, R Mitrut, ...
Farmacia 65 (6), 877-884, 2017
172017
Challenges in the differential diagnosis of COVID-19 pneumonia: a pictorial review
CM Marginean, M Popescu, CM Vasile, R Cioboata, P Mitrut, ...
Diagnostics 12 (11), 2823, 2022
82022
Risk Factors and Genetic Predisposition in Colorectal Cancer: A Study on Young and Old Adults
CB Petre-Mandache, DN Margaritescu, R Mitrut, AM Kamal, V Padureanu, ...
Current Health Sciences Journal 47 (1), 84, 2021
42021
Effect of perinatal exposure to glyphosate and its mixture with 2, 4-D and dicamba on rat dam kidney and thyroid function and offspring's health
AO Docea, AE Cirstea, L Cercelaru, AI Drocas, V Dinca, R Mesnage, ...
Environmental Research 237, 116908, 2023
32023
Changes in biochemical parameters in diabetes after successful direct-acting antiviral treatment of hepatitis c virus
MS Popescu, DM Firu, V Padureanu, CM Marginean, DC Pirvu, A Osman, ...
Farmacia 70 (4), 643-651, 2022
22022
Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units
S Genc, A Taghizadehghalehjoughi, ME Naldan, O Gülcü, C Caglayan, ...
Experimental and Therapeutic Medicine 27 (2), 1-11, 2024
12024
Gut–Brain Axis, Microbiota and Probiotics—Current Knowledge on Their Role in Irritable Bowel Syndrome: A Review
CM Marginean, M Popescu, AI Drocas, SM Cazacu, R Mitrut, ...
Gastrointestinal Disorders 5 (4), 517-535, 2023
12023
4CPS-127 Anti-osteoporosis medication in females: assessing the patient’s knowledge
MN Obloja, AO Docea, S Ianosi, F Gherghina, G Ianosi, P Mitrut, ...
European Journal of Hospital Pharmacy 25 (Suppl 1), A101-A101, 2018
12018
Curcumin in the Treatment of Melanoma
E Gofita, D Calina, A Blendea, C Brandusa, R Mitrut, AO Docea
Trends Toxicol. Relat. Sci 1, 21-40, 2017
12017
EXPOSURE TO GLYPHOSATE AND ITS MIXTURE WITH DICAMBA AND 2, 4-D FROM GESTATIONAL DAY 6 UNTIL WEANING IN RAT DAMS REVEALS SIGNS OF NON-ALCOHOLIC FATTY LIVER DISEASE.
AE Cirstea, AO Docea, L Cercelaru, AI Drocas, R Mitrut, R Mesnage, ...
Farmacia 71 (6), 2023
2023
Diagnostic Approach and Pathophysiological Mechanisms of Anemia in Chronic Liver Disease—An Overview
CM Marginean, D Pirscoveanu, M Popescu, AO Docea, A Radu, ...
Gastroenterology Insights 14 (3), 327-341, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20